Appointments

  • Michael Aldridge appointed Focal Medical CEO

    Biopharmaceutical company Focal Medical, Inc. has announced the appointment of Michael Aldridge as the Company’s new Chief Executive Officer (CEO). Focal Medical develops novel therapeutic products based on its innovative and patent protected local drug delivery technology platform. Aldridge joins the company with more than 25 years of experience in the biopharma industry. Aldridge led [...]

  • Mark Gladwell appointed as Sapphiros CEO and President

    Privately-held consumer diagnostic portfolio company Sapphiros has announced the promotion of Mark Gladwell from chief operating officer (COO) to President and Chief Executive Officer (CEO). As COO, Gladwell established and expanded the operating footprint of the company and integrated its diverse portfolio of operating entities, including Biocrucible, GoToKnow, Satio, GrapheneDx and Flexotronix Limited. Gladwell has [...]

  • Faiza Hughell appointed as Tebra CRO

    Healthcare operating system provider Tebra announced that Faiza Hughell has joined the company as Chief Revenue Officer (CRO). Hughell will lead the sales, account management and channel organisations to drive customer and revenue growth across all customer segments. She will report directly to co-founder and CEO, Dan Rodrigues. Rodrigues said: “We are thrilled to welcome [...]

  • Another Round appoints Jesse Shanahan as CTO

    Digital fitness startup Another Round has appointed Jesse Shanahan as CTO. The company applies its proprietary AI to personal training, making it more accessible, convenient and effective. Shanahan has extensive experience in data science and tech innovation, including developing and leading projects with a focus on delivering machine learning and artificial intelligence products. Shanahan was [...]

  • Agilio announces two senior appointments

    Healthcare technology firm Agilio Software has announced the appointment of Neil Laycock as its new CEO and Andy Sloan as its new Dental Managing Director. Agilio supports the primary care, dental, and hospital sectors, providing compliance, HR, and e-learning software solutions to over 70,000 dental professionals in the UK and 4,400 GP practices in England. [...]

  • Veranex announces dual appointments

    Med tech industry service provider Veranex has announced the appointment of industry veteran Tom Daulton as chief executive officer (CEO). Former CEO David Dockhorn is assuming the newly created role of chief operating officer (COO). Daulton has over 30 years of healthcare leadership experience, joining from National Dentex Labs, where he served as chairman and [...]

  • AnHeart Therapeutics announces two appointments

    Clinical stage biotechnology company AnHeart Therapeutics has announced two new appointments. The company, which develops novel precision oncology therapeutics, has appointed Heinrich Farin, M.D. as Senior Medical Director of Clinical Research and Michael J. Humphries, Ph.D., as VP and Head of US Medical Affairs. Dr Farin has more than 20 years of experience in clinical [...]

  • MedTech Europe announces new CEO

    Trade association MedTech Europe has announced the appointment of Oliver Bisazza as its new Chief Executive Officer, with effect from January 2, 2023. Bisazza will succeed Serge Bernasconi who has announced his retirement. The new CEO has more than 15 years of professional experience in Brussels, including industrial policies roles in trade associations representing medtech [...]

  • Maternova appoints Luna Mehrain, MD, MSc, as CMO

    Global health solutions company Maternova, Inc. has announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer. The obstetrician, gynaecologist and strategic leader in reproductive, maternal and neonatal health, will assess the efficacy, safety and usability of Maternova’s diagnostics and therapeutic medical innovations. Dr Mehrain will also be responsible for training the [...]

  • Sudo Biosciences appoints new Chief Business Officer

    Sudo Biosciences, a biopharmaceutical company that designs and develops a broad pipeline of TYK2 (tyrosine kinase 2) inhibitors, has announced the appointment of Imran Babar, Ph.D., as chief business officer. Dr Babar has extensive experience in in healthcare strategy, life sciences finance, operations and business development. Scott Byrd, CEO, Sudo Biosciences, said: “Imran brings to [...]